Description
Studies suggest that combining psychedelic-assisted therapy and meditation practices can enhance the beneficial effects of both interventions. This planned study will investigate how specific meditation techniques, when combined with psilocybin treatment, can mitigate certain challenges and risks, and impact therapeutic effects towards optimising mental health treatment outcomes.
The Clinical Psychedelic Lab at Monash University is Australia's first psychedelic lab, leading a rigorous program of research in psychedelic medicine that seeks to evaluate therapeutic effects, innovate on treatment design, mitigate known risks, explore potential drawbacks, and understand therapeutic mechanisms. We're a warm and ambitious group of researchers and clinicians working to develop and test best practice across multiple psychedelic therapies and for several different mental health conditions. There are various active and upcoming projects within the group, and this project is listed as an example among many options. To see other possible project ideas, visit this page: https://www.monash.edu/medicine/scs/clinical-psychedelic-lab/support-us
To find out more about the lab, go to www.monash.edu/psychedelics
Essential criteria:
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords
psychedelics, psychedelic-assisted psychotherapy, psilocybin, mdma, dmt, 5meo-dmt, therapist training, hallucinogens
School
School of Clinical Sciences at Monash Health / Hudson Institute of Medical Research » Psychiatry
Available options
PhD/Doctorate
Masters by research
Masters by coursework
Honours
BMedSc(Hons)
Time commitment
Full-time
Part-time
Top-up scholarship funding available
No
Physical location
Notting Hill
Research webpage